UBS AM’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-116,324
| Closed | -$2.8M | – | 2758 |
|
|
2023
Q2 | $2.8M | Hold |
116,324
| – | – | ﹤0.01% | 1493 |
|
|
2023
Q1 | $2.8M | Buy |
116,324
+48,279
| +71% | +$1.16M | ﹤0.01% | 1493 |
|
|
2022
Q4 | $719K | Buy |
68,045
+38,329
| +129% | +$405K | ﹤0.01% | 2017 |
|
|
2022
Q3 | $134K | Sell |
29,716
-22,135
| -43% | -$99.6K | ﹤0.01% | 2658 |
|
|
2022
Q2 | $207K | Buy |
51,851
+181
| +0.4% | +$724 | ﹤0.01% | 2574 |
|
|
2022
Q1 | $378K | Buy |
51,670
+1,048
| +2% | +$7.67K | ﹤0.01% | 2541 |
|
|
2021
Q4 | $284K | Buy |
50,622
+10,411
| +26% | +$58.5K | ﹤0.01% | 2690 |
|
|
2021
Q3 | $257K | Buy |
40,211
+511
| +1% | +$3.27K | ﹤0.01% | 2649 |
|
|
2021
Q2 | $335K | Buy |
39,700
+12,400
| +45% | +$105K | ﹤0.01% | 2629 |
|
|
2021
Q1 | $287K | Hold |
27,300
| – | – | ﹤0.01% | 2494 |
|
|
2020
Q4 | $462K | Hold |
27,300
| – | – | ﹤0.01% | 2322 |
|
|
2020
Q3 | $350K | Hold |
27,300
| – | – | ﹤0.01% | 2270 |
|
|
2020
Q2 | $385K | Buy |
+27,300
| New | +$385K | ﹤0.01% | 2214 |
|